Pfizer Inc. (PFE) is a multinational pharmaceutical and biotechnology firm. It researches, develops, and manufactures biopharmaceutical merchandise throughout a spread of various areas, together with oncology, heart problems, inflammatory illnesses, immunology, uncommon illnesses, and vaccines. In collaboration with BioNTech SE (BNTX), a German-based biotechnology firm, Pfizer developed an mRNA-based vaccine in opposition to COVID-19. The Pfizer-BioNTech vaccine has been administered to hundreds of thousands of individuals within the U.S. and overseas, and gross sales might enhance additional because the U.S. and different nations administer booster pictures to additional shield folks from the virus.
On Aug. 23, 2021, the U.S. Meals and Drug Administration (FDA) accredited the Pfizer-BioNTech COVID-19 vaccine, which is now being marketed as Comirnaty. Beforehand, the vaccine was solely accredited beneath emergency use authorization (EUA). It turned the primary vaccine in opposition to COVID-19 to realize full approval from the FDA. The vaccine continues to be out there beneath EUA, together with for people between the ages of 12 and 15.
Pfizer’s 12-month trailing internet earnings and income are $13.2 billion and $51.6 billion, respectively. The corporate’s market cap is about $248.4 billion. These monetary information are as of Sept. 16, 2021.
“Insider” refers to folks in senior administration positions and members of the board of administrators, in addition to folks or entities that personal greater than 10% of the corporate’s inventory. On this context, it has nothing to do with insider buying and selling.
High 3 Particular person Insider Shareholders
The shares owned by particular person insider shareholders are these which might be held by direct possession. Shares talked about on this part don’t embrace shares held not directly nor shares accessible by inventory choices. Firm insiders should file an SEC Form 4 each time they purchase or promote an quantity of the corporate’s inventory that’s deemed to be materials.
Frank A. D’amelio
Frank A. D’amelio owns a complete of 483,188 Pfizer shares, representing 0.01% of the corporate’s complete shares outstanding. D’amelio is chief monetary officer (CFO) and government vice chairman of International Provide. He oversees the corporate’s company finance features, which embrace audit, treasury, tax, insurance coverage, enterprise finance and analytics, and extra. D’amelio was liable for main Pfizer’s acquisition of Wyeth Prescribed drugs, King Prescribed drugs, Hospira Inc., Anacor Prescribed drugs Inc., and Medivation Inc. He additionally led the spinoff of Zoetis, the corporate’s animal well being enterprise, in addition to the sale of its diet enterprise. Earlier than becoming a member of Pfizer in 2007, D’amelio labored for Alcatel-Lucent as chief administrative officer and senior government vice chairman of Integration.
John Douglas Younger
John Douglas Younger owns a complete of 461,761 Pfizer shares, representing 0.01% of the corporate’s complete shares excellent. Younger has been with Pfizer for greater than 30 years and is the corporate’s group president and chief enterprise officer. Previous to his present position, he was group president of Pfizer Revolutionary Well being, which included six separate enterprise items targeted on creating progressive medicines and vaccines. Younger was additionally liable for increasing Pfizer’s footprint in rising markets in Latin America, Asia, Africa, and the Center East. Earlier than that, he was group president for Pfizer Important Well being. Younger additionally serves as a member of the board of administrators of the Shopper Healthcare three way partnership with GlaxoSmithKline PLC (GSK), in addition to on the board of Johnson Controls Worldwide PLC (JCI).
Mikael Dolsten owns a complete of 137,727 Pfizer shares, representing fewer than 0.01% of the corporate’s complete shares excellent. Dolsten is Pfizer’s chief scientific officer and president of Worldwide Analysis, Improvement and Medical (WRDM). His focus is on creating scientific breakthroughs in small-molecule medicines, biotherapeutics, gene therapies, and vaccines. As president of WRDM, Dolsten oversees all of Pfizer’s analysis items, together with Oncology, Inside Drugs, Irritation & Immunology, Vaccines, Uncommon Illness, and the Facilities for Therapeutic Innovation. Earlier than becoming a member of Pfizer in 2009, he served because the president of Wyeth Analysis, and earlier than that, as government vice chairman and head of Worldwide Analysis at Boehringer Ingelheim. Dolsten is the inventor on a number of patents and has printed roughly 150 articles in worldwide journals.
High 3 Institutional Shareholders
Institutional buyers maintain between 65-66% of Pfizer’s complete shares excellent.
Vanguard Group Inc.
Vanguard Group owns 456.2 million shares of Pfizer, representing 8.1% of complete shares excellent, based on the corporate’s 13F submitting for the interval ending June 30, 2021. The corporate is primarily a mutual fund and ETF administration firm with about $7.2 trillion in world property beneath administration (AUM). The Vanguard S&P 500 ETF (VOO) is without doubt one of the firm’s largest exchange-traded funds (ETFs) with about $256 billion in AUM. Pfizer contains practically 0.7% of VOO’s holdings.
BlackRock owns 407.0 million shares of Pfizer, representing 7.3% of complete shares excellent, based on the corporate’s 13F submitting for the interval ending June 30, 2021. The corporate is primarily a mutual fund and ETF administration firm with roughly $8.7 trillion in AUM. The iShares Core S&P 500 ETF (IVV) is amongst one in all BlackRock’s largest ETFs with roughly $305 billion in AUM. Pfizer contains practically 0.7% of IVV’s holdings.
State Avenue Corp.
State Avenue owns 278.6 million shares of Pfizer, representing 5.0% of complete shares excellent, based on the corporate’s 13F submitting for the interval ending June 30, 2021. The corporate is primarily a supervisor of mutual funds, ETFs and different property with roughly $3.9 trillion in AUM. The SPDR S&P 500 ETF Belief (SPY) is amongst one in all State Avenue’s largest ETFs with roughly $410 billion in AUM. Pfizer contains practically 0.7% of SPY’s holdings.